跳至主要内容
临床试验/EUCTR2012-003914-15-AT
EUCTR2012-003914-15-AT进行中(未招募)1 期

Continuos versus periodic intravenous iron supplementation in maintenance hemodialysis patients

Medizinische Universität Wien, Klinik für Innere Medizin III, Klin. Abteilung für Nephrologie und Dialyse0 个研究点目标入组 140 人开始时间: 2014年5月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients with anemia and end-stage renal disease on maintenance hemodialysis
  • Hemoglobin = 8,5 g/dl
  • Ferritin < 1000 mg/dl
  • TSAT < 50%
  • CRP < 5 mg/dl
  • Age> 18 years
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 70
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • Hemoglobin < 8,5 g/dl
  • Pregnancy and nursing period
  • Prior allergic reaction on intravenous iron therapy or known allergy on ingredients of the IMP
  • Chronic infectious disease (HIV, Hep B, Hep C)
  • Malignant tumor disease
  • Active infection (CRP > 5 mg/dl, antibiotic treatment – except prophylactic antibiotic treatment)
  • Patients on oral iron therapy at study inclusion
  • Simultaneous participation in another clinical trial
  • Active bleeding
  • Surgical treatment within four weeks prior study inclusion
  • Mental disorder
  • Blood transfusion within four weeks prior study inclusion
  • Drug or alcohol abuse
  • Asthma bronchiale
  • Atopic disease

研究者

发起方
Medizinische Universität Wien, Klinik für Innere Medizin III, Klin. Abteilung für Nephrologie und Dialyse

相似试验